Stockscreener 앱 받기
7.61
9.34%
0.65
전일 마감가:
$6.96
열려 있는:
$7.09
하루 거래량:
1.00M
Relative Volume:
6.69
시가총액:
$132.31M
수익:
-
순이익/손실:
$-7.29M
주가수익비율:
-6.7747
EPS:
-1.1233
순현금흐름:
$-7.00M
1주 성능:
+4.97%
1개월 성능:
+61.91%
6개월 성능:
+94.13%
1년 성능:
+813.89%
1일 변동 폭
$6.85
$7.78
1주일 범위
$5.875
$7.78
52주 변동 폭
$0.677
$7.78
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
명칭
Lixte Biotechnology Holdings Inc
전화
310 203 2902
주소
433 PLAZA REAL, BOCA RATON
Compare LIXT vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
7.61 | 132.31M | 0 | -7.29M | -7.00M | -1.1233 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Lixte Biotechnology Holdings Inc 주식(LIXT)의 최신 뉴스
LIXT Announces Plans to Acquire NOMAD Transportable Power Systems - GuruFocus
Lixte Biotechnology Provides $6.5 Million Secured Note to NOMAD Ahead of Planned Merger - TradingView
LIXTE (NASDAQ: LIXT) funds NOMAD with $6.5M secured bridge loan - Stock Titan
A Nasdaq Company Just Reinvented Itself as a Power Company — and Bet It All on the AI Energy Crunch - markets.businessinsider.com
LIXTE to loan $6.5M to NOMAD ahead of acquisition close - Investing.com UK
The AI Boom’s Real Bottleneck Is Power — and One Nasdaq Company Is Reinventing Itself to Solve It - GlobeNewswire
LIXTE to loan $6.5M to NOMAD ahead of acquisition close By Investing.com - Investing.com Nigeria
LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026 - Yahoo Finance
Lixte Biotechnology Holdings Inc (LIXT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lixte Biotechnology Holdings Inc (LIXT) Institutional Confidence - TradingKey
Lixte Biotechnology Holdings Inc (LIXT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lixte Biotechnology Holdings Inc (LIXT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Lixte Biotechnology Holdings Inc - TradingKey
Lixte Biotechnology Holdings Inc (LIXT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Lixte Biotechnology Holdings Inc (LIXT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lixte Biotechnology Holdings Inc (LIXT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lixte Biotechnology Holdings Inc (LIXT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lixte Biotechnology Holdings Inc (LIXTW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lixte Biotechnology Holdings Inc (LIXTW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lixte Biotechnology to Acquire Nomad Transportable Power Systems in Stock Deal of Up to 53.5M Shares - TradingView
LIXTE (NASDAQ: LIXT) to buy NOMAD and pivot into mobile grid-scale BESS - Stock Titan
Lixte Biotechnology Holdings Inc (LIXTW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lixte Biotechnology Holdings Inc (LIXTW) Institutional Confidence - TradingKey
Lixte Biotechnology Holdings Inc (LIXTW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lixte Biotechnology Holdings Inc (LIXTW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lixte Biotechnology Holdings Inc (LIXTW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Lixte Biotechnology Holdings Inc (LIXTW) Valuation: PE, PB & Fair Value Analysis - TradingKey
From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch - marketscreener.com
LIXTE Biotechnology sings deal to acquire 100% of NOMAD to meet grid demand - MSN
Lixte Biotechnology Shares Down on Plans for Nomad Transportable Power Deal, Name Change - Moomoo
LIXT Transforms from Biotech to Power Infrastructure Amid AI Dem - GuruFocus
LIXT Enters Agreement to Acquire Nomad Transportable Power Syste - GuruFocus
LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, Pivots to Energy Storage - MEXC
The New Bottleneck Isn’t Computing Power — It’s Just Power - The Globe and Mail
Lixte Biotechnology to Acquire Nomad Power Systems; to Change Name After Acquisition - Moomoo
Lixte Biotechnology to acquire NOMAD Power Systems - Investing.com
Lixte Biotechnology to acquire NOMAD Power Systems By Investing.com - Investing.com South Africa
LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS) - The Manila Times
LIXTE Biotechnology Holdings, Inc. to Acquire NOMAD Transportable Power Systems, Inc. and Rebrand as NOMAD Power Solutions - Quiver Quantitative
Mobile grid batteries for AI boom: LIXTE to acquire NOMAD BESS leader - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
LIXTE to acquire NOMAD Transportable Power Systems for BESS pivot - grafa.com
Lixte Biotechnology Holdings (LIXT) Advances 3.3% as Investors Eye Key Resistance at $7.21Low Vol ETF - newsline.com
Lixte Biotechnology (NASDAQ:LIXT) holders report 5.1% stake in company - Stock Titan
Lixte Biotechnology Holdings, Inc. (LIXT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Lixte Biotechnology Announces At-the-Market Equity Financing - TipRanks
Lixte Biotechnology Raises $16.6 Million in Registered Direct Offering of Stock and Pre-Funded Warrants - TradingView
Lixte (NASDAQ: LIXT) closes $16.6M registered direct stock sale - Stock Titan
Lixte (NASDAQ: LIXT) sells 2.37M shares and 258,859 pre-funded warrants for $16.6M - Stock Titan
Lixte Biotechnology raises $16.6 million in direct offering - Investing.com UK
LIXTE Biotechnology prices $16.6M registered direct offering - MSN
Lixte Biotechnology Holdings Inc (LIXT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
1.44%
자본화:
|
볼륨(24시간):